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DNA-Protein Cross-Links as a Biomarker of Cr(VI) Exposure
We would like to provide some observations regarding a paper by Zhitkovich et al. (1) that appeared in EHP Supplements. In highly elevated blood chromium levels), lymphocyte DPC levels were no greater than in the control group (6) . In the other occupational and environmental Cr(VI) DPC studies (7-10), all of which reported increased DPC in the exposed population, chromium body burdens were measured in the exposed group only (8-J1), or were measured in both the exposed and control groups and found to be the same (2) . In short, no investigator has yet identified a chromium-exposed population that has shown both an increase in lymphocyte DPC levels and a chromium body burden relative to a contemporaneously sampled control group.
The animal data are also inconclusive. For example, lymphocyte DPC levels were not increased in rats fed 100-200 ppm Cr(VI) (1,000-2,000 times the drinking water standard), even though tissue chromium levels indicated that significant chromium absorption had occurred (11) . The in vivo animal data that support a causal relationship reported a 2-to 4-fold increase in lymphocyte DPC in rats injected intraperitoneally (ip) with 40 mg/kg chromate (12) , but even these results must be considered in light of the fact that another investigator using the same dosing regimen (but a different cell preparation technique) showed no increase in lymphocyte DPC (11 (4) , we feel that some clarification is appropriate. The study, which involved five different laboratories testing many different metal compounds, demonstrated that while each lab obtained the same qualitative results regarding which metals induced DPC (copper, arsenic, and chromium) and those which did not (mercury, magnesium, permanganate, cadmium, lead, and aluminum), the actual degree of DPC measured in each lab was highly variable. For example, the increase in DPC induced by arsenic trioxide at 150 pm ranged from 8-to 60-fold. Although several possibilities for the interlaboratory variability were discussed, we believe that it may be premature to term the DPC assay as "validated"; we would encourage more research into the reproducibility of the method.
There are some apparent contradictions in the summary (1) state that there were no confounders present in any of the six studies cited. It is indeed a rare epidemiologic study that has no confounders, much less an accumulated body of studies. There were, in fact, significant confounders present in most and probably all of the studies, which the authors themselves described in some detail. For example, in the three studies of welders (7) (8) (9) , there was coexposure to nickel, a known cross-linking agent, and a variety of oxides and metal salts. As noted by Costa et al. (7) in their study ofwelders, ... the possible presence of confounding factors, such as smoking and diet, reported to be associated with crosslinks [ 141 does not allow a definitive conclusion.
In a preliminary report on the same study, it was noted that "...we did observe increased cross-linking but are unsure of the agent involved" (15) . Also, as noted in the Bulgarian chrome-plater study (6), ... it is difficult to say with certainty whether the increase in DPC was due to chromium or some other chemical.
Confounding factors were also present in the "environmentally exposed" populations because their corresponding control groups were comprised in part [New Jersey (10) ] or completely [Bulgaria (6)] of individuals from rural areas with significantly less industrial air pollution. In summary, we believe it is somewhat overreaching to conclude that these studies were completely free of all confounding factors.
Second, there appear to be some conflicting conclusions reached in the various studies, and we believe these warrant more discussion than given by Zhitkovich et al. (1) . For example, in one study of welders (7) , white blood cell DPC levels were increased over those of unexposed controls, but there was no difference in blood chromium levels between the two groups. Costa et al. (2) assumed a priori that Cr(VI) exposure had occurred and suggested that DPC may therefore be a more sensitive biomarker than blood chromium concentrations. However, in the Bulgarian chrome platers (6), blood chromium levels were significantly elevated (almost 10-fold) above controls, a clear indication that chromium exposure had occurred; yet there was no difference in DPC levels in the exposed group versus the control group. These findings are directly contradictory: DPC was elevated in workers with negative evidence of Cr(VI) exposure, and DPC was not elevated in workers with clear evidence of Cr(VI) exposure. The findings related to the`environmentally exposed" groups are also inconsistent. For example, Table 1 (16) did not measure environmental Cr(VI) levels in Jambol. They simply concluded that the Jambol residents must have been exposed to Cr(VI) because their mean blood chromium level was higher than in residents from another town (Burgas). Yet this assumption is internally inconsistent with the fact that Costa et al. (6) found no difference in DPC levels between the chrome platers and the Jambol residents, two groups with tremendous differences in blood chromium levels. Other such inconsistencies can be found, and as a result we do not believe the epidemiologic evidence is yet sufflicient to conclude that DPC is a proven biomarker for Cr(VI) exposure.
We believe that a simple, rapid, and reliable biomarker for screening or quantitating Cr(VI) exposure would be a very valuable tool. For 
